Ken Mills is the founding President and Chief Executive Officer of REGENXBIO. He was previously the Chief Financial Officer and Vice President of Business Development at Meso Scale Diagnostics, a privately held life sciences company. There, he served as a member of the founding management team, and worked to establish the company’s operations and ongoing business strategy. In this position, Mr. Mills supervised all company activities, including direct management of corporate and business development, strategic planning, finance, and accounting activities. Prior to his tenure at Meso Scale Diagnostics, he was Director of Business Development for IGEN International, a medical diagnostics company. Mr. Mills received an S.B. in Chemistry from the Massachusetts Institute of Technology.